J&J stock trades higher Q4 revenue hit by forex COVID vaccine impact, FY23 outlook

Cristina Arias/Cover via Getty Images

Johnson & Johnson (NYSE:JNJ) stock is trading higher premarket on Tuesday after the company’s Q4 results and an EPS outlook seen above estimates.

Q4 adjusted EPS grew +10.3% Y/Y to $2.35, beating analysts expectations. However, reported sales declined -4.4% Y/Y to $23.71B, and missed